Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 5:00 pm Purchase | 2025-02-11 | 13D | Sera Prognostics, Inc. SERA | Chione Ltd. | 2,605,351 7.600% | 625,001 (+31.56%) | Filing History |
| 2024-07-10 8:34 pm Unchanged | 2024-06-30 | 13G | Acrivon Therapeutics, Inc. Common Stock ACRV | Chione Ltd. | 3,848,632 12.500% | 0 (Unchanged) | Filing History |
| 2024-07-10 8:29 pm Sale | 2023-12-31 | 13G | Acrivon Therapeutics, Inc. Common Stock ACRV | Chione Ltd. | 3,848,632 17.300% | -7,965 (-0.21%) | Filing History |
| 2023-02-14 3:41 pm Sale | 2022-12-31 | 13G | Karyopharm Therapeutics Inc. KPTI | Chione Ltd. | 293,333 3.900% | -40,000 (-12.00%) | Filing History |
| 2022-11-28 3:59 pm Purchase | 2022-11-17 | 13G | Acrivon Therapeutics, Inc. Common Stock ACRV | Chione Ltd. | 3,856,597 18.500% | 3,856,597 (New Position) | Filing History |
| 2022-02-11 2:54 pm Sale | 2021-12-31 | 13G | Karyopharm Therapeutics Inc. KPTI | Chione Ltd. | 333,333 6.600% | -33,333 (-9.09%) | Filing History |
| 2021-07-26 5:19 pm Purchase | 2021-07-15 | 13D | Sera Prognostics, Inc. SERA | Chione Ltd. | 1,980,350 6.800% | 1,980,350 (New Position) | Filing History |
| 2021-02-16 4:03 pm Sale | 2020-12-31 | 13G | Karyopharm Therapeutics Inc. KPTI | Chione Ltd. | 366,667 7.500% | -13,033 (-3.43%) | Filing History |